Adherence to GLP-1 receptor agonists and SGLT2 inhibitors by out-of-pocket spending among Medicare beneficiaries with diabetes.

美國 Medicare 糖尿病受益人自付費用對 GLP-1 receptor agonists 與 SGLT2 inhibitors 依從性的影響